CathWorks
0 followers
About CathWorks
CathWorks develops and markets the FFRangio system, a drug-free, wire-free physiologic assessment tool for the entire coronary tree. The technology combines artificial intelligence and advanced computational science to derive physiologic information from routine angiograms, enabling quick, intraprocedural evaluation of coronary function without stimulation or invasive pressure wires. The company serves interventional cardiology across multiple geographies, providing real-time hemodynamic insights to support clinical decision making in coronary interventions.